Vascular pathologies and cognition in a population-based cohort of elderly people

Journal of the Neurological Sciences

Volumn 226, Issue 1-2 SPEC.ISS., 2004, Pages 13-17

  Fernando, Malee S ^a   Ince, Paul G ^a  

^a Liver Group   (United Kingdom)

Author keywords

Alzheimer type pathologies; Cognitive Function and Ageing Study (CFAS); Congophilic amyloid angiopathy

Indexed keywords

AGED; AGING; ALZHEIMER DISEASE; COGNITION; COHORT ANALYSIS; CONFERENCE PAPER; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; MULTIINFARCT DEMENTIA; MULTIVARIATE ANALYSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PREVALENCE; PRIORITY JOURNAL; PSYCHOMETRY; QUESTIONNAIRE; RISK FACTOR; SCORING SYSTEM; UNITED KINGDOM; VASCULAR AMYLOIDOSIS; VASCULAR DISEASE; WHITE MATTER;

AGED; ALZHEIMER DISEASE; BRAIN; CEREBRAL AMYLOID ANGIOPATHY; CEREBROVASCULAR DISORDERS; COGNITION DISORDERS; COHORT STUDIES; DEMENTIA, VASCULAR; HUMANS; POPULATION;

EID: 8644240928     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2004.09.004     Document Type: Conference Paper

References (23)

1. MRC CFAS Cognitive function and dementia in six areas of England and Wales: the distribution of MMSE and prevalence of GMS organicity level in the MRC CFA study Psychol. Med. 28 1998 319 335
2. J. Copeland, M. Dewey, and H. Griffiths-Jones Computerised psychiatric diagnostic system and case nomenclature for elderly subjects Psychol. Med. 16 1986 89 99
3. D. Kay, M. Dewey, I. McKeith, M. O'Cuill, C. McCracken, and A. Fairbairn Do experienced diagnosticians agree about the diagnosis of dementia from survey data? The effects of informants' reports and interviewers' vignettes Int. J. Geriatr. Psychiatry 13 1998 852 862
4. A. Yip, C. Brayne, D. Easton, D. Rubinsztein MRC CFAS Apolipoprotein E is only a weak predictor of dementia and cognitive decline in the general population J. Med. Genet. 39 2002 639 643
5. A.M. Saunders, W.J. Strittmatter, D. Schmechel, P.H. St George Hyslop, M.A. Pericak-Vance, and S.H. Joo Association of apolipoprotein E allele 4 with late onset familial and sporadic Alzheimer's disease Neurology 43 1993 1467 1472
6. W.J. Strittmatter, A.M. Saunders, D. Schmechel, A.M. Pericak-Vance, J. Enghild, and G.S. Salvesen Apolipoprotein E: high avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer's disease Proc. Natl. Acad. Sci. 90 1993 1977 1981
7. C. Tysoe, D. Galinsky, D. Robinson, C. Brayne, F. Huppert, and T. Dening Apo E and Apo CI are associated with dementia in younger but not older late-onset cases Dement. Geriatr. Cogn. Disord. 9 1998 191 198
8. Neuropathology Group of MRC CFAS Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales Lancet 357 2001 169 175
9. S.S. Mirra, A. Heyman, D. McKeel, S. Sumi, B. Crain, and L. Brownlee The consortium to establish a registry of Alzheimer's disease (CERAD): Part II. Standardization of the neuropathologic assessment of Alzheimer's disease Neurology 41 1991 479 486
10. D. Davis, F. Scmitt, D. Wekstein, and W. Markesbery Alzheimer neuropathologic alterations in aged cognitively normal subjects J. Neuropathol. Exp. Neurol. 58 1999 376 388
11. H. Braak, and E. Braak Neuropathological staging of Alzheimer-related changes Acta Neuropathol. 82 1991 239 259
12. D. Knopman, J. Parisi, A. Salviati, M. Floriach-Robert, B. Boeve, and R. Ivnik Neuropathology of cognitively normal elderly J. Neuropathol. Exp. Neurol. 62 2003 1087 1095
13. E. Englund, and A. Brun White matter changes in dementia of Alzheimer' type: the difference in vulnerability between cell compartments Histopathology 16 1990 433 439
14. A. Brun, and E. Englund A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study Ann. Neurol. 19 1986 253 262
15. F. Fazekas, R. Kleinert, H. Offenbacher, R. Schmidt, G. Kleinert, and F. Payer Pathologic correlates of incidental MRI white matter signal hyperintensities Neurology 43 1993 1683 1689
16. L. Bronge, N. Bogdanovic, and L.-O. Wahlund Postmortem MRI and histopathology of white matter changes in Alzheimer brains Dementia 13 2002 205 212
17. M.M.B. Breteler, J.C. van Swieten, M.L. Bots, J.J. Claus, D.E. Grobbee, and J. van Gijn Cerebral white matter lesions, vascular risk factors, and cognitive function in a population based study: the Rotterdam Study Neurology 44 1994 1246 1252
18. P. Scheltens, F. Barkhof, D. Leys, E. Wolters, R. Ravid, and W. Kamphorst Histopathologic correlates of white matter changes on MRI in Alzheimer's disease and normal aging Neurology 45 1995 883 888
19. I. Räihä, S. Tarvonen, T. Kurki, T. Rajala, and L. Sourander Relationship between vascular risk factors and white matter lesion attenuation of the brain Acta Neurol. Scand. 87 1997 286 289
20. S. Yamaji, K. Ishii, M. Sasaki, T. Imamura, H. Kitagaki, and S. Sakamoto Changes in cerebral blood flow and oxygen metabolism related to magnetic resonance imaging white matter hyperintensities in Alzheimer's disease J. Nucl. Med. 38 1997 1471 1474
21. H. Nagara, T. Inoue, T. Koga, T. Kitaguchi, J. Tateishi, and I. Goto Formalin fixed brains are useful for magnetic resonance imaging (MRI) study J. Neurol. Sci. 81 1987 67 77
22. S.T. Grafton, S.M. Sumi, G.K. Stimac, E.C. Alvord, C.-M. Shaw, and D. Nochlin Comparison of postmortem magnetic resonance imaging and neuropathologic findings in the cerebral white matter Arch. Neurol. 48 1991 293 298
23. M. Fernando, J. O'Brien, R. Perry, F. Esteves, G. Forster, and W. McMeekin Comparison of pathology of cerebral white matter with postmortem MRI in the elderly Neuropathol. Appl. Neurobiol. 30 2004 385 395